Rate My Professor Jonathan Williman

Dr Jonathan Williman is a Senior Research Fellow and Biostatistician in the Department of Public Health at the University of Otago, Christchurch, within the Faculty of Medicine. He holds a BSc(Hons), a PhD in Immunology from the University of Otago, and an MBiostat. His professional career has centered on biostatistics applied to population health, with a focus on developing population-based health innovations, protecting public health, and reducing health inequalities. Williman possesses extensive experience across diverse research domains, including laboratory studies, surveillance and epidemiological investigations, and clinical trials. Following his PhD, he served as a Health Information Analyst with the Population and Environmental Health Group at the Institute of Environmental Science and Research. In 2009, he was appointed Research Fellow in the Addictions Program at the National Institute of Health Innovation, University of Auckland. He joined the University of Otago, Christchurch, in 2012, where he contributes to the Biostatistics and Computational Biology Unit, offering collaborative research and statistical support to staff and postgraduate students across the campus.

Williman's research contributions are evidenced by numerous peer-reviewed publications in high-impact journals. Key works include 'Accelerating care, capacity and equity in automated insulin delivery systems for New Zealanders with type 1 diabetes: The ACCESS-AID study protocol' (Journal of Diabetes & Metabolic Disorders, 2026), 'Glycemic outcomes during outpatient use of automated insulin delivery without meal announcement in adults with type 1 diabetes: Results from the CLOSE IT randomized controlled trial' (Diabetes Technology & Therapeutics, 2026), 'Sociodemographic characteristics of Aotearoa New Zealand oral health students: Do student cohorts reflect the society they will serve?' (Journal of the Royal Society of New Zealand, 2026), 'Rapid postpartum progression to diabetes following early antenatal prediabetes: Evidence from a multiethnic New Zealand cohort' (Diabetes Care, 2026), and 'Trends in community antibiotic dispensing for children and young people in Aotearoa New Zealand, 2010-2019: Implications for antimicrobial stewardship' (Journal of Paediatrics & Child Health, 2025). He is a member of the New Zealand Statistical Association and the Australasian Epidemiological Association, underscoring his standing in biostatistics and epidemiology.